Consultant & Head of Scientific Affairs
HND, B-Tec, BSc, PhD
Our management team and medical advisory board are comprised of well reputed professionals who possess considerable knowledge in managing and exploiting innovative medical devices in orthopaedics and other surgical markets.More about us
Dr Harry Chana is a qualified computational chemist with experience as a quality control analyst, pre-clinical toxicologist and senior formulation scientist. He has worked for Glaxo Smith Kline characterising drug products, University of Birmingham as a computational chemist on crystal structure prediction of organic molecules using computational techniques, Covance Laboratories as a Senior Inhalation Scientist on pre-clinical toxicology studies establishing the toxicological nature of test compounds on selected test species and Vectura as a Senior Formulation Scientist on reformulation of patent expired respiratory drug products.
Harry is involved in supporting the product engineering team with scientific matters and medical device development.Meet the team